StreetInsider.com News Articles

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

Tue, 12 May 2026 07:05:00 -0400

CARMEL, Ind., May 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter period ended March 31, 2026.

1Q26 Financial Highlights

Revenues increased 80% year over year to $1.6M, reflecting the AMA Category I CPT® code assignment for Percutaneous Electrical Nerve Field Stimulation (PENFS) effective January 1, 2026, substantially increasing payor coverage.
Expanded gross margin by 200 basis points and improved operating loss

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

Tue, 12 May 2026 07:05:00 -0400

1Q26 Financial Highlights

Revenues increased 80% year over year to $1.6M, reflecting the AMA Category I CPT® code assignment for Percutaneous Electrical Nerve Field Stimulation (PENFS) effective January 1, 2026, substantially increasing payor coverage.
Expanded gross margin by 200 basis points and improved operating loss

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

Tue, 12 May 2026 07:05:00 -0400

1Q26 Financial Highlights

Revenues increased 80% year over year to $1.6M, reflecting the AMA Category I CPT® code assignment for Percutaneous Electrical Nerve Field Stimulation (PENFS) effective January 1, 2026, substantially increasing payor coverage.
Expanded gross margin by 200 basis points and improved operating loss

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

Tue, 12 May 2026 07:05:00 -0400

1Q26 Financial Highlights

Revenues increased 80% year over year to $1.6M, reflecting the AMA Category I CPT® code assignment for Percutaneous Electrical Nerve Field Stimulation (PENFS) effective January 1, 2026, substantially increasing payor coverage.
Expanded gross margin by 200 basis points and improved operating loss

Form 10-Q Neuraxis, INC For: Mar 31

Tue, 12 May 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260512/26472796.html

Form 10-Q Neuraxis, INC For: Mar 31

Tue, 12 May 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260512/26472796.html

Form 10-Q Neuraxis, INC For: Mar 31

Tue, 12 May 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260512/26472796.html

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Tue, 05 May 2026 07:00:00 -0400

CARMEL, Ind., May 05, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its first quarter 2026, for the period ended March 31, 2026, on Tuesday, May 12, 2026, before market open. The Company has scheduled a conference call for the same day, Tuesday, May 12, 2026, at 9:00 am ET to review the results.

Conference Call Details

Date and Time: Tuesday, May 12, 2026, at 9:00am ET

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Tue, 05 May 2026 07:00:00 -0400

Conference Call Details

Date and Time: Tuesday, May 12, 2026, at 9:00am ET

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Tue, 05 May 2026 07:00:00 -0400

Conference Call Details

Date and Time: Tuesday, May 12, 2026, at 9:00am ET

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

Tue, 05 May 2026 07:00:00 -0400

Conference Call Details

Date and Time: Tuesday, May 12, 2026, at 9:00am ET

Form SCHEDULE 13G/A Neuraxis, INC Filed by: BIGGER CAPITAL FUND L P

Fri, 01 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260501/26417886.html

Form SCHEDULE 13G/A Neuraxis, INC Filed by: BIGGER CAPITAL FUND L P

Fri, 01 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260501/26417886.html

Form SCHEDULE 13G/A Neuraxis, INC Filed by: BIGGER CAPITAL FUND L P

Fri, 01 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260501/26417886.html

Form 4 Neuraxis, INC For: Apr 28 Filed by: Aharon Gil

Thu, 30 Apr 2026 19:18:00 -0400

si-local-file:///var/storage/secattach/20260430/26410721.html

Form 4 Neuraxis, INC For: Apr 28 Filed by: Aharon Gil

Thu, 30 Apr 2026 19:18:00 -0400

si-local-file:///var/storage/secattach/20260430/26410721.html

Form DEFA14A Neuraxis, INC

Tue, 28 Apr 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260428/26385311.html

Form DEFA14A Neuraxis, INC

Tue, 28 Apr 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260428/26385311.html

Form DEFA14A Neuraxis, INC

Tue, 28 Apr 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260428/26385311.html

Form DEF 14A Neuraxis, INC For: Jun 10

Tue, 28 Apr 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260428/26385271.html

Form DEF 14A Neuraxis, INC For: Jun 10

Tue, 28 Apr 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260428/26385271.html

Form DEF 14A Neuraxis, INC For: Jun 10

Tue, 28 Apr 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260428/26385271.html

Form ARS Neuraxis, INC For: Dec 31

Tue, 28 Apr 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260428/26385252.html

Form ARS Neuraxis, INC For: Dec 31

Tue, 28 Apr 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260428/26385252.html

Form ARS Neuraxis, INC For: Dec 31

Tue, 28 Apr 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260428/26385252.html